13F Holdings
中文EN

MD Pediatrix Medical Group, Inc.

Services-Hospitals · NYSE · SEC CIK 893949 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.9%
TTM net income YoY-7.5%
TTM EPS YoY-4.2%
Revenue 3-yr CAGR-0.9%
Net income 3-yr CAGR17.1%

Margins

Gross margin—
Operating margin10.9%
Net margin7.7%
FCF margin—
EBITDA margin12.1%

Returns

ROE17.2%
ROA6.9%
ROIC (approx.)13.8%
Asset turnover0.90x

Leverage & solvency

Liabilities / assets60.3%
Debt / equity0.68x
Current ratio1.28x
Interest coverage6.38x

Cash quality & payout

Operating cash flow / net income1.51x
Accruals ratio-3.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.91B$2.01B$1.99B$1.97B$1.91B
SG&A expense$240.79M$238.44M$227.54M$231.40M$263.36M
Operating income$208.81M-$68.71M$7.32M$172.69M$202.92M
Interest expense$35.97M$40.74M$42.08M$39.70M$68.72M
Pretax income$216.43M-$101.34M-$48.36M$81.37M$135.23M
Income tax$51.04M-$2.27M$12.05M$18.81M$27.24M
Net income$165.39M-$99.07M-$60.41M$66.33M$130.96M
EBITDA$230.64M-$36.49M$43.49M$208.32M$235.06M
EPS (basic)1.97-1.19-0.730.791.54
EPS (diluted)1.94-1.19-0.730.791.53
Weighted avg. shares (diluted)85.27M83.33M82.20M84.12M85.83M
Balance sheet
Cash & equivalents$375.24M$229.94M$73.26M$9.82M$387.39M
Short-term investments$124.48M$118.57M$104.48M$93.24M$99.72M
Receivables$229.66M$259.99M$272.31M$296.79M$301.77M
Current assets$763.51M$639.61M$483.45M$427.99M$840.56M
PP&E, net$39.18M$39.17M$75.64M$73.29M$70.15M
Goodwill$1.26B$1.24B$1.38B$1.53B$1.51B
Intangibles$16.86M$11.60M$21.24M$18.49M$21.57M
Total assets$2.25B$2.15B$2.22B$2.35B$2.72B
Current liabilities$458.91M$434.11M$388.95M$426.98M$427.37M
Short-term debt$26.81M$20.55M$14.91M$14.90M$2.49M
Long-term debt$570.53M$597.12M$618.42M$632.38M$989.70M
Total debt$597.34M$617.66M$633.33M$647.28M$992.19M
Total liabilities$1.38B$1.39B$1.37B$1.46B$1.83B
Shareholders' equity$865.85M$764.94M$849.06M$891.63M$896.49M
Net debt$222.10M$387.72M$560.08M$637.46M$604.80M
Shares outstanding82.98M85.87M84.02M82.95M86.42M
Cash flow statement
Operating cash flow$271.09M$206.57M$137.32M$166.94M$76.74M
Investing cash flow-$18.30M-$35.41M-$48.18M-$56.95M-$53.07M
Financing cash flow-$107.49M-$14.48M-$25.71M-$487.55M-$760.12M
Depreciation & amortization$21.83M$32.23M$36.17M$35.64M$32.15M
Stock-based compensation$18.05M$11.87M$12.32M$16.13M$18.97M
Share buybacks$86.68M$1.70M$919,000$88.51M$4.72M

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.